Seeking Alpha

Teva (TEVA -1.4%) makes a few management changes to its executive leadership team, appointing...

Teva (TEVA -1.4%) makes a few management changes to its executive leadership team, appointing SVP Allan Oberman to President and CEO of Teva Americas Generics, replacing current chief executive William Marth who will step down and retire at the end of 2013. The company also promotes Jill DeSimone to the newly created position of SVP and General Manager of Teva Global Women’s Health franchise. Ms. DeSimone is a seasoned veteran in specialty medicine franchising, and will manage all aspects of building the business.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector